[HTML][HTML] Pharmaceutical company responses to Canadian opioid advertising restrictions: A framing analysis
The pharmaceutical industry's promotion of opioids in North America has been well-
documented. Yet despite the clear consequences of improperly classifying pharmaceutical …
documented. Yet despite the clear consequences of improperly classifying pharmaceutical …
[PDF][PDF] Opioid use and overdose: what we've learned in Ontario
T Gomes, DN Juurlink - Healthc Q, 2016 - greenroommed.ca
Opioid Use and Overdose: What We’ve Learned in Ontario Page 1 8 Healthcare Quarterly
Vol.18 No.4 2016 ICES Report Abstract The dramatic rise in prescription opioid use in the …
Vol.18 No.4 2016 ICES Report Abstract The dramatic rise in prescription opioid use in the …
[HTML][HTML] Tamper-resistant drugs cannot solve the opioid crisis
There are many reasons why tamper-resistant formulations will not curb the opioid epidemic
overall. First, many such formulations simply include naloxone, which can counteract the …
overall. First, many such formulations simply include naloxone, which can counteract the …
Building a framework for the evaluation of knowledge translation for the Canadian Network for Observational Drug Effect Studies
IS Sketris, N Carter, RL Traynor, D Watts… - … and Drug Safety, 2020 - Wiley Online Library
Abstract Purpose The Canadian Network for Observational Drug Effect Studies (CNODES),
a network of pharmacoepidemiologists and other researchers from seven provincial sites …
a network of pharmacoepidemiologists and other researchers from seven provincial sites …
[BOOK][B] Identifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada
T Gomes - 2017 - pure.uva.nl
The use of opioids to treat chronic non-cancer pain is the subject of considerable debate
due to a lack of evidence of efficacy when used over long durations, and increasing …
due to a lack of evidence of efficacy when used over long durations, and increasing …
